The U.S. Food & Drug Administration has issued an urgent medical device correction for certain insulin pumps manufactured by ...

A man with type 1 diabetes has produced his own insulin after receiving cell transplant, eliminating the need for ...

A proof-of-concept study finds that donated insulin-producing cells can be genetically modified to avoid provoking the ...

While insulin is the cornerstone treatment for type 1 diabetes a new study reveals that leptin a hormone that helps maintain ...

The first drug that can slow the onset of type 1 diabetes has been given the green light for use in the UK. Teplizumab has ...

A man with type 1 diabetes has become the first patient to produce his own insulin after receiving genetically engineered ...

Early device failures, prior authorizations, and not receiving 90-days’ worth of supplies contribute to the problem.

A medical device manufacturer has issued an urgent correction for select insulin pumps due to a possible error that could ...

A price cap on insulin from one of the three major manufacturers took effect on New Year's Day, giving more Americans with diabetes more affordable treatments. As of Jan. 1, 2024, Sanofi cut the ...

As a result, the U.S. is a global outlier on money spent on insulin products. The U.S. represents only 15% of the global insulin market, but generates nearly 50% of the industry’s insulin revenue.

Daily insulin shots for the management of Type 1 and Type 2 diabetes could become a thing of the past, and insulin pills could someday be another option for diabetes patients. In people with Type ...

In one study, with a dose of 10 units of insulin lispro, the mean (±SD) peak insulin action was 99±39 minutes, as compared with 179±93 minutes for regular insulin (P<0.05). 11 In a study of ...